Biotech & Bioprocessing

The modern biomanufacturing landscape faces a persistent bottleneck where the transition from laboratory discovery to commercial-scale production often results in significant performance losses. Traditional screening methods frequently rely on microfluidic droplets or well plates that do not

Global chocolate consumption continues to surge toward a projected market value of nearly thirty-eight billion dollars by 2029, even as traditional cacao farming faces an existential threat from climate instability and ethical controversies. This widening gap between demand and sustainable supply

The treatment of rare metabolic disorders represents one of the most demanding frontiers in modern biotechnology, where the margin for error is measured in hours and the patients are often only days old. Ivan Kairatov, a seasoned biopharma expert with a deep specialization in regenerative medicine

The rapid advancement of biotechnology across the African continent has created an urgent demand for a new generation of policy experts capable of managing complex biological risks while fostering scientific innovation. To meet this critical need, the School of Public Health’s Pandemic Center has

Chronic obstructive pulmonary disease has long remained a primary cause of global mortality, yet the therapeutic options available to millions of suffering patients have seen little fundamental change for decades. This persistent challenge took a major turn on March 27, 2026, when AstraZeneca

The global pharmaceutical supply chain is currently navigating a high-stakes transition where the ability to manufacture complex biologics at scale has become the definitive bottleneck for medical advancement. As traditional small-molecule drugs give way to sophisticated injectable therapies, the